Cargando…

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life

INTRODUCTION AND BACKGROUND: Choosing the right treatment for the right patient in a setting of metastatic cancer disease remains a challenge. To facilitate clinical decision-making, predictive tools have been developed to personalize treatment. Here, we aim to assess the use of the recently propose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christ, Sebastian M., Schettle, Markus, Willmann, Jonas, Ahmadsei, Maiwand, Seiler, Annina, Blum, David, Guckenberger, Matthias, Andratschke, Nicolaus, Hertler, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038557/ https://www.ncbi.nlm.nih.gov/pubmed/35496816 http://dx.doi.org/10.1016/j.ctro.2022.04.005

Ejemplares similares

Prevalence and predictors for 72-h mortality after transfer to acute palliative care unit
por: Christ, Sebastian M., et al.
Publicado: (2022)

Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

Socio-economic determinants for the place of last care: results from the acute palliative care unit of a large comprehensive cancer center in a high-income country in Europe
por: Christ, Sebastian M., et al.
Publicado: (2023)

Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy
por: Ahmadsei, Maiwand, et al.
Publicado: (2022)

Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer center
por: Christ, Sebastian M., et al.
Publicado: (2023)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Efficacy and safety analysis in metastatic cancer patients treated with multiple courses of repeat radiation therapy
por: Ahmadsei, Maiwand, et al.
Publicado: (2023)

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)

Sex-specific and gender-specific aspects in patient-reported outcomes
por: Hertler, Caroline, et al.
Publicado: (2020)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT
por: Ahmadsei, Maiwand, et al.
Publicado: (2023)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

Long-term cancer survivors treated with multiple courses of repeat radiation therapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
por: Westphal, Sophia, et al.
Publicado: (2021)

Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology
por: Kraft, Johannes, et al.
Publicado: (2021)

Prospective randomized clinical studies involving reirradiation: update of a systematic review
por: Nieder, Carsten, et al.
Publicado: (2023)

Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
por: Kovacs, Boldizsar, et al.
Publicado: (2023)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

Leveraging Advances in Artificial Intelligence to Improve the Quality and Timing of Palliative Care
por: Windisch, Paul, et al.
Publicado: (2020)

Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
por: Lapaeva, Mariia, et al.
Publicado: (2022)

Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic
por: Christ, Sebastian M., et al.
Publicado: (2022)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
por: Chamberlain, Madalyne, et al.
Publicado: (2021)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Patient-specific quality assurance strategies for synthetic computed tomography in magnetic resonance-only radiotherapy of the abdomen
por: Dal Bello, Riccardo, et al.
Publicado: (2023)

Intra- and inter-fraction breath-hold variations and margins for radiotherapy of abdominal targets
por: Ehrbar, Stefanie, et al.
Publicado: (2023)

Palliative Surgical Resection of an Extensive Metastatic Cardiac Myxofibrosarcoma
por: Karangelis, Dimos, et al.
Publicado: (2019)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2012)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
por: Christ, Sebastian M., et al.
Publicado: (2023)

Synthetic computed tomography for low-field magnetic resonance-only radiotherapy in head-and-neck cancer using residual vision transformers
por: La Greca Saint-Esteven, Agustina, et al.
Publicado: (2023)

Deep-Learning-Based Dose Predictor for Glioblastoma–Assessing the Sensitivity and Robustness for Dose Awareness in Contouring
por: Poel, Robert, et al.
Publicado: (2023)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
por: John, Caroline, et al.
Publicado: (2021)

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
por: Lee, Anna, et al.
Publicado: (2021)

MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands
por: van Timmeren, Janita E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_97h0hp1c15qmt68e0oe93thp8f